Literature DB >> 18697840

Guanylate binding protein-1 inhibits spreading and migration of endothelial cells through induction of integrin alpha4 expression.

Kristina Weinländer1, Elisabeth Naschberger, Michael H Lehmann, Philipp Tripal, Wolfgang Paster, Hannes Stockinger, Christine Hohenadl, Michael Stürzl.   

Abstract

Human guanylate binding protein-1 (GBP-1) is a large GTPase that is induced by inflammatory cytokines and acts antiangiogenically through the inhibition of endothelial cell proliferation and migration. In this study, we detected that GBP-1-expressing cells show a significantly reduced spreading and migration on fibronectin matrices. Investigating possible mechanisms of these effects, we found that integrin alpha(4) (ITGA4) was consistently up-regulated at both the RNA and protein level in GBP-1-expressing cell cultures. Inhibition of cell spreading and migration by GBP-1 was dependent on the binding of ITGA4 to fibronectin. The inflammatory cytokines IL-1beta and TNF-alpha induced ITGA4 expression in HUVECs and inhibited spreading and migration. Knockdown of GBP-1 by shRNA abrogated inflammatory cytokine induced ITGA4 expression and restored spreading and migration capabilities of the cells. These results show that inhibition of endothelial cell spreading and migration by inflammatory cytokines is mediated by GBP-1 through induction of ITGA4 expression. Endothelial cell migration is a key process during angiogenesis. Therefore, ITGA4 may be a novel molecular target to modulate angiogenesis in human disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18697840     DOI: 10.1096/fj.08-107524

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  26 in total

1.  Interferon gamma-induced human guanylate binding protein 1 inhibits mammary tumor growth in mice.

Authors:  Karoline Lipnik; Elisabeth Naschberger; Nathalie Gonin-Laurent; Petra Kodajova; Helga Petznek; Stefanie Rungaldier; Simonetta Astigiano; Silvano Ferrini; Michael Stürzl; Christine Hohenadl
Journal:  Mol Med       Date:  2010-02-05       Impact factor: 6.354

2.  IFN-γ drives inflammatory bowel disease pathogenesis through VE-cadherin-directed vascular barrier disruption.

Authors:  Victoria Langer; Eugenia Vivi; Daniela Regensburger; Thomas H Winkler; Maximilian J Waldner; Timo Rath; Benjamin Schmid; Lisa Skottke; Somin Lee; Noo Li Jeon; Thomas Wohlfahrt; Viktoria Kramer; Philipp Tripal; Michael Schumann; Stephan Kersting; Claudia Handtrack; Carol I Geppert; Karina Suchowski; Ralf H Adams; Christoph Becker; Andreas Ramming; Elisabeth Naschberger; Nathalie Britzen-Laurent; Michael Stürzl
Journal:  J Clin Invest       Date:  2019-11-01       Impact factor: 14.808

Review 3.  Pathophysiological role of guanylate-binding proteins in gastrointestinal diseases.

Authors:  Nathalie Britzen-Laurent; Christian Herrmann; Elisabeth Naschberger; Roland S Croner; Michael Stürzl
Journal:  World J Gastroenterol       Date:  2016-07-28       Impact factor: 5.742

4.  Viral inhibitor of apoptosis vFLIP/K13 protects endothelial cells against superoxide-induced cell death.

Authors:  Mathias Thurau; Gaby Marquardt; Nathalie Gonin-Laurent; Kristina Weinländer; Elisabeth Naschberger; Ramona Jochmann; Khaled R Alkharsah; Thomas F Schulz; Margot Thome; Frank Neipel; Michael Stürzl
Journal:  J Virol       Date:  2008-11-05       Impact factor: 5.103

5.  Hepatic gene expression profile in mice perorally infected with Echinococcus multilocularis eggs.

Authors:  Bruno Gottstein; Matthias Wittwer; Marc Schild; Michael Merli; Stephen L Leib; Norbert Müller; Joachim Müller; Rolf Jaggi
Journal:  PLoS One       Date:  2010-04-01       Impact factor: 3.240

6.  Intracellular trafficking of guanylate-binding proteins is regulated by heterodimerization in a hierarchical manner.

Authors:  Nathalie Britzen-Laurent; Michael Bauer; Valeria Berton; Nicole Fischer; Adrian Syguda; Simone Reipschläger; Elisabeth Naschberger; Christian Herrmann; Michael Stürzl
Journal:  PLoS One       Date:  2010-12-07       Impact factor: 3.240

7.  The interferon-gamma-induced murine guanylate-binding protein-2 inhibits rac activation during cell spreading on fibronectin and after platelet-derived growth factor treatment: role for phosphatidylinositol 3-kinase.

Authors:  Angela F Messmer-Blust; Sujata Balasubramanian; Victoria Y Gorbacheva; Jonathan A Jeyaratnam; Deborah J Vestal
Journal:  Mol Biol Cell       Date:  2010-05-26       Impact factor: 4.138

8.  Limited systemic sclerosis patients with pulmonary arterial hypertension show biomarkers of inflammation and vascular injury.

Authors:  Sarah A Pendergrass; Everett Hayes; Giuseppina Farina; Raphael Lemaire; Harrison W Farber; Michael L Whitfield; Robert Lafyatis
Journal:  PLoS One       Date:  2010-08-17       Impact factor: 3.240

9.  Gamma interferon-induced guanylate binding protein 1 is a novel actin cytoskeleton remodeling factor.

Authors:  Nicole Ostler; Nathalie Britzen-Laurent; Andrea Liebl; Elisabeth Naschberger; Günter Lochnit; Markus Ostler; Florian Forster; Peter Kunzelmann; Semra Ince; Verena Supper; Gerrit J K Praefcke; Dirk W Schubert; Hannes Stockinger; Christian Herrmann; Michael Stürzl
Journal:  Mol Cell Biol       Date:  2013-11-04       Impact factor: 4.272

10.  Expression and localization of axin 2 in colorectal carcinoma and its clinical implication.

Authors:  Ute Schaal; Sandra Grenz; Susanne Merkel; Tilman T Rau; Michel V Hadjihannas; Elisabeth Kremmer; Priya Chudasama; Roland S Croner; Jürgen Behrens; Michael Stürzl; Elisabeth Naschberger
Journal:  Int J Colorectal Dis       Date:  2013-05-24       Impact factor: 2.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.